Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis

  • Rami S. Komrokji
  • , John F. Seymour
  • , Andrew W. Roberts
  • , Martha Wadleigh
  • , L. Bik To
  • , Robyn Scherber
  • , Elyce Turba
  • , Andrew Dorr
  • , Joy Zhu
  • , Lixia Wang
  • , Tanya Granston
  • , Mary S. Campbell
  • , Ruben A. Mesa

Research output: Contribution to journal › Article › peer-review

124 Scopus citations

Fingerprint

Dive into the research topics of 'Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science